EMA decision on AstraZeneca vaccine expected on Thursday

The EMA remains of the view that the benefits of the AstraZeneca vaccine in preventing Covid-19, with its associated risk of hospitalisation and death, outweigh the risks of side effects. File picture: Marc O'Sullivan

The European Medicines Agency (EMA) is to make a final decision on the AstraZeneca vaccine on Thursday, “concluding on the information” available.

The vaccine has been paused in a number of countries, including Ireland, due to a small number of reports of some people suffering blood clots following vaccination.